Whitehawk Therapeutics (WHWK) EBT Margin (2018 - 2025)
Historic EBT Margin for Whitehawk Therapeutics (WHWK) over the last 7 years, with Q1 2025 value amounting to 201.92%.
- Whitehawk Therapeutics' EBT Margin rose 1397200.0% to 201.92% in Q1 2025 from the same period last year, while for Sep 2025 it was 717.23%, marking a year-over-year decrease of 4711800.0%. This contributed to the annual value of 245.13% for FY2024, which is 249100.0% up from last year.
- According to the latest figures from Q1 2025, Whitehawk Therapeutics' EBT Margin is 201.92%, which was up 1397200.0% from 252.42% recorded in Q4 2024.
- In the past 5 years, Whitehawk Therapeutics' EBT Margin registered a high of 114.21% during Q4 2021, and its lowest value of 4563.33% during Q1 2021.
- Moreover, its 5-year median value for EBT Margin was 266.35% (2022), whereas its average is 580.18%.
- The largest annual percentage gain for Whitehawk Therapeutics' EBT Margin in the last 5 years was 39626800bps (2022), contrasted with its biggest fall of -1521300bps (2022).
- Whitehawk Therapeutics' EBT Margin (Quarter) stood at 114.21% in 2021, then tumbled by -133bps to 266.35% in 2022, then increased by 3bps to 257.18% in 2023, then increased by 2bps to 252.42% in 2024, then increased by 20bps to 201.92% in 2025.
- Its last three reported values are 201.92% in Q1 2025, 252.42% for Q4 2024, and 173.95% during Q3 2024.